ANVISA Approval [Regulatives / Guidelines]

posted by H_Rotter – Germany, 2006-01-27 15:00 (7099 d 10:16 ago) – Posting: # 68
Views: 13,996

Dear shiv,

it's different from the FDA.
The center(s) performing the study must follow ANVISA's rules (http://www.anvisa.gov.br/eng/legis/resol/103_03rdc_e.htm), must be inspected (http://www.anvisa.gov.br/eng/bio/form_bio.doc), and renew their status anually (http://www.anvisa.gov.br/eng/bio/form_renewal.rtf). After approval of the protocol by the local IEC, the study may be performed.

Only if your protocol deviates from ANVISA's standards (e.g. if you want to perform at multiple dose study in order to reduce variability for HVDs), I would strongly recommend contacting them before.

good luck!
Hermann Rotter

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,678 registered users;
24 visitors (0 registered, 24 guests [including 13 identified bots]).
Forum time: 02:17 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5